A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen capture

Fatema, K., Snowden, J.S., Watson, A. et al. (4 more authors) (2025) A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen capture. International Journal of Biological Macromolecules, 305 (Part 2). 141152. ISSN 0141-8130

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2025 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Keywords: Vaccine; Platform; Virus-like particle; ClearColi; HBcAg; Junín virus
Dates:
  • Published: May 2025
  • Published (online): 15 February 2025
  • Accepted: 14 February 2025
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Molecular and Cellular Biology (Leeds) > Molecular Virology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 21 Feb 2025 15:43
Last Modified: 06 Mar 2025 10:54
Published Version: https://www.sciencedirect.com/science/article/pii/...
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.ijbiomac.2025.141152
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Export

Statistics